OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase 2a Study of Baxdrostat in Primary Aldosteronism

HTML

Year: 2025
Type: article
Study design: Clinical Trial
Source: New England Journal of Medicine
DOI: 10.1056/nejmc2508629
Authors: Adina F. Turcu, Mason W. Freeman, Irina Bancos, Anat Ben-Shlomo, Oksana Hamidi, Amir H. Hamrahian, Wenyu Huang, Lawrence S. Kirschner, Ramin Sam, Ashwini Mallappa, Bonifride Tuyishimire, Aina S. Lihn, Shira Perl, Morris J. Brown
Institutions: University of Michigan, Harvard University, Mayo Clinic, Cedars-Sinai Medical Center, The University of Texas Southwestern Medical Center, Johns Hopkins University, Northwestern University, The Ohio State University Wexner Medical Center, University of California, San Francisco, AstraZeneca (United States), AstraZeneca (Sweden), Queen Mary University of London
Language: English

Topic: Hormonal Regulation and Hypertension
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: baxdrostat, primary aldosteronism, aldosterone synthase inhibitors, hypertension, hypokalemia
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W4412376043
FWCI: 32.21
Cites: 5
Cited by: 76
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security